Patients with cancer have a significantly higher risk of VTE. How do we assess risk for developing VTE in patients with cancer? Is there a role for primary VTE prophylaxis in cancer patients? If so what are our treatment options? On this podcast, our expert hematologist Dr Jean Connors delves into these questions and more.

VTE Prophylaxis in Patients with Cancer with Dr. Jean Connors

This podcast from NEJM Resident 360 takes a deep dive into key topics with expert clinicians and educators. As we explore the details of pathophysiology and critique the evidence behind clinical practice, these conversations are intended to give you better understanding of the topic and greater confidence when treating your patients.

Share VTE Prophylaxis in Patients with Cancer with Dr. Jean Connors

Sign up to save your podcasts

VTE Prophylaxis in Patients with Cancer with Dr. Jean Connors

VTE Prophylaxis in Patients with Cancer with Dr. Jean Connors

More shows like Curbside Consults

NEJM This Week

NEJM Interviews

JAMA Clinical Reviews

Clinical Conversations

Core IM | Internal Medicine Podcast

Leadership Conversations

Run the List

NEJM AI Grand Rounds

Intention to Treat

Not Otherwise Specified